Women & Employment Making your life work! • Re-visionlng • Re-focusing • Re-tooling Saturday, April 3 9:00am to 5:00pm EMU Register at Women'* Crater, Salle 3, EMC • 346-4095 SAM’S ON CAMPUS sandwiches We Bake Our Bread Fresh Daily FREE DELIVERY 50* OFF sm. sandwich 1/2 foot axp. 4/12/23 75* OFF med. sandwich 3/4 foot exp. 4/12/93 S1»0FF family size 2 foot exp. 4/12/93 804 E. 12th corner of 12th 81 Alder 343-1141 New AIDS vaccine faces tests WASHINGTON (AP) — Researchers will lest experi mental vaccines on children infected with HIV, the deadly vims that causes AIDS, the National Institute of Health said Monday Ninety children ages one month to 12 years will receive three vaccines, officials said The tests will be children 2 years old or younger, to enable researchers to com pare their reactions to the vaccine with those of older patients, officials said The symptoms of AIDS show up more quickly in children infected with the HIV virus than in adults Alxmt half the infants born with the IfIV virus develop a serious AIDS-related infection between the ages of 3 and fi Tliis is the first time we have tried HIV vaccines on children Laurie K. Doepel, National Institute of Health Atmut 10 vaccines have been tested on adults. Preliminary results of these trials show that some of the vaccines increased the body's immunological response to HIV. Them have been suggestions, for instance, that some vaccines might stabilize the loss of CD-4 white-blood cells, scien tists said. The University of Rochester Medical School has received formal approval to Iiegin the tests, and tri als of the three experimental HIV vac nines will eventually he conducted at other sites, said Dr. fames McNamara, a medical officer at the Nation al Institute of Allergies and Infectious Diseases. Each child will receive one shot every four weeks for six months and will be checked for 24 weeks after the Inst immunization for signs of physical reactions, such as fevers or swelling. McNamara said researchers also will try to determine if low or high doses of the vaccines c ause any immune reactions. The tests were informally announced last month at a meeting of the American Association for the Advancement of Science in Boston. The genetically engineered vaccines to be tested am made with parts of the HIV virus The vaccines am made by MicroGeneSys Inc. of Meriden, Conn.; Genontech Inc:, of South San Francisco, Clalif.; and Biocine, a joint venture of Chiron and CIBA-Geigy based in Emeryville, Calif. ET ALS MKf riw.s Student Senate will u«wt UhU\ «l ft p m in I Ml Cnnlurs K«k»ii> A f or itH»w kntofflM non. mil 14i» t*»tu MISt IU-ANMHSS t tirri Planning and Plnrmml S*r*«p will hiMuirM v> tk*Mnbifi|t the»t w whit )i tn;i*t iw iltnuM fit under •i«od the interview* prm t*n totlay from 11 JO a m to 12 30 p m «l»d front i 10 to 4 30 p tit and Men ft 31 front 1 to f* p ttt in Room 221 Moftdrtt k» Mali t or more tnfor malum